Abbott Laboratories (ABT) vs Koninklijke Philips N.V. (PHG)
Abbott Laboratories and Koninklijke Philips N.V. are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $174.8B against $24.0B — 7.3× the size. Koninklijke Philips N.V. trades at the lower P/E: 18.2× against 32.8×. Koninklijke Philips N.V. grew revenue faster over the last twelve months: 9.11% against 8.06%. Abbott Laboratories has the higher net margin (11.7% vs 6.24%) and the lower return on invested capital (5.83% vs 6.69%). Both pay a dividend; Koninklijke Philips N.V. yields more (4.19% vs 1.88%). Across the 23 metrics below, Koninklijke Philips N.V. leads on 13 and Abbott Laboratories on 10.
Valuation
Profitability
| Metric | ABT | PHG | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.61% | 45.93% | 56.01% |
| Operating margin | 15.77% | 9.64% | (15.03%) |
| Net margin | 11.65% | 6.24% | (20.40%) |
| Free cash flow margin | 16.80% | 8.99% | (7.24%) |
| Return on equity | 10.58% | 10.20% | (15.32%) |
| Return on assets | 5.62% | 4.21% | (19.72%) |
| Return on invested capital | 5.83% | 6.69% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack